Actress Alex Kingston, known for roles on “ER” and “Doctor Who,” has revealed she was diagnosed with uterine cancer last year. In an interview with The Independent, published Friday, the 62-year-old ...

Former "ER" and "Doctor Who" star Alex Kingston has shared the "sneaky" symptoms that led to a "shock" diagnosis of uterine cancer. Kingston spoke to the British newspaper The Independent in a story ...

1 Department of Anaesthesiology, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China 2 Shanghai Key Laboratory of Embryo ...

Use of hair dyes was associated with an increased incidence of uterine fibroids among Black women, especially those at least 32 years of age. Hair dye use is associated with a higher incidence of ...

Rina-S has received FDA breakthrough therapy designation for advanced endometrial cancer after standard treatments fail, based on promising Phase 1/2 trial results. The RAINFOL-01 trial showed ...

ABC News anchor Linsey Davis is going public for the first time about her lengthy battle with uterine fibroids, a condition that has repeatedly disrupted her health and daily life. “I suffered in ...

A group of Black women lawmakers is leading a new effort to address the racial disparities surrounding uterine fibroids and uterine cancer. On Tuesday, Senators Lisa Blunt Rochester and Angela ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

The projections come as data shows increases in uterine cancer cases and deaths. Uterine cancer cases in the U.S. will rise significantly by 2050, with Black women three times more likely to die from ...

Please provide your email address to receive an email when new articles are posted on . Both incidence and mortality rates for uterine cancer are expected to increase through 2050. Black women will ...

Rina-S showed a 50% confirmed response rate in heavily pretreated advanced endometrial cancer patients, with two complete responses observed. The phase 1/2 results support Rina-S as a potential ...